[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fRSoRQrMgjnibpFINMvEv1wQ5K3a23xrltR0TKYJApcg":8,"$fu3TqUN0ND5VIcuFmLyiKEHvCtuEU-lgwDmCHpmFJQRk":55,"$fDN8PGtYfzNt3xA6FMR5_C7JKOR2c8C9dsmImI839Eq4":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},66812,863402,[],"https://ystcdn.venuertc.com/learnMaterial/ystApp//0Rvlsm1tdkSbq5L99bjhchaojzwJ5kCw.png","华晓萍","浙江大学医学院附属妇产科医院","妇科","主治医师",94,0,"复发性卵巢癌化疗药物使用全指南：安全用药的7个关键细节","","https://ystcdn.venuertc.com/venue/AI/d7af5c80-fdc4-4848-b1dd-16be1c71a820.jpg","\u003Cdiv class=\"custom-ovca-container\">\n  \u003Ch2 id=\"material_title\" class=\"custom-ovca-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">复发性卵巢癌化疗药物使用全指南：安全用药的7个关键细节\u003C/h2>\n  \n  \u003Cdiv class=\"custom-ovca-section\" style=\"background: linear-gradient(90deg, #f8fafc 70%, #e8eaf6 100%);\">\n    \u003Ch2 class=\"custom-ovca-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">开场导语 🌿\u003C/h2>\n    \u003Cp class=\"custom-ovca-p\">\n      谈到复发性卵巢癌的治疗，化疗药物是目前不可或缺的重要选择。不少患者和家属在实际用药过程中，会遇到服用时间、剂型选择、不良反应管理等各种细节疑惑。本文将梳理关于这些药物的7个核心用药细节，包括正确的服用方法、剂型、药物相互作用、不良反应处理、储存方式等，帮助您在安全前提下规范使用这些药品，提升治疗效果，更安心地配合医生治疗。\n    \u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"custom-ovca-section\" style=\"background: linear-gradient(90deg, #f5f7fa 60%, #f1f8e9 100%);\">\n    \u003Ch2 class=\"custom-ovca-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01. 化疗药物的基本组成与作用原理 🧬\u003C/h2>\n    \u003Cp class=\"custom-ovca-p\">\n      复发性卵巢癌化疗常见药物包括铂类（如顺铂、卡铂）、紫杉烷类（如紫杉醇、紫杉油醇）、PARP抑制剂（如奥拉帕利）、吉西他滨以及支持用药（如升白细胞药、护肝药）等。这些药物分为静脉注射和口服两大类。\n    \u003C/p>\n    \u003Cp class=\"custom-ovca-p\">\n      \u003Cb>铂类化疗药\u003C/b>通过与DNA结合，抑制其复制与修复，使肿瘤细胞凋亡。\u003Cb>紫杉烷类\u003C/b>可阻碍纺锤体形成，防止细胞正常分裂。\u003Cb>PARP抑制剂\u003C/b>则专门针对带有BRCA变异或HRD阳性的患者，干扰细胞DNA修复过程，让异常细胞更易被清除（Ledermann et al., 2012）。\n    \u003C/p>\n    \u003Cp class=\"custom-ovca-tip\">\n      \u003Cspan class=\"custom-tip-emoji\">💡\u003C/span> 正确理解不同药物的作用，为后续合理使用打下基础。\n    \u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"custom-ovca-section\" style=\"background: linear-gradient(90deg, #f3e5f5 50%, #e3f2fd 100%);\">\n    \u003Ch2 class=\"custom-ovca-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02. 药物剂型与正确服用方法 🎯\u003C/h2>\n    \u003Cp class=\"custom-ovca-p\">\n      常见化疗药有静脉注射剂型（如卡铂、紫杉醇，也有口服片剂或胶囊形式（如奥拉帕利、尼拉帕利）。使用方式需严格遵循医生指示。\n    \u003C/p>\n    \u003Cul class=\"custom-ovca-ul\">\n      \u003Cli>\n        \u003Cb>静脉注射药\u003C/b>须由医护人员在正规的医疗机构操作，患者需按时就诊，不可自行增减次数。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>口服药\u003C/b>应在固定时间，用足量清水送服，切勿嚼碎。肠溶片、缓释剂型严禁掰开或研碎，避免影响药效。\n      \u003C/li>\n      \u003Cli>\n        服药期间，忌与葡萄柚汁或富含维生素C的饮品同服，以防影响代谢。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"custom-ovca-tip\">\n      \u003Cspan class=\"custom-tip-emoji\">🕑\u003C/span> 如果忘记服用一次，及时补服；但两次服药时间接近时，跳过漏服剂量，不可双倍补服。\n    \u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"custom-ovca-section\" style=\"background: linear-gradient(90deg, #e0f2f1 60%, #fffde7 100%);\">\n    \u003Ch2 class=\"custom-ovca-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03. 剂量规格与个体化方案调整 ⚖️\u003C/h2>\n    \u003Cp class=\"custom-ovca-p\">\n      不同药品有多种规格。例如卡铂注射剂常见100mg/瓶、150mg/瓶；奥拉帕利片剂有100mg与150mg两类。具体用量需按体重、肾功能、既往用药情况综合评估。\n    \u003C/p>\n    \u003Cul class=\"custom-ovca-ul\">\n      \u003Cli>\n        老年患者、体重偏轻者（如\u003Cem>病例：73岁女士、体重45kg\u003C/em>），常需减量起始，减少副反应风险。\n      \u003C/li>\n      \u003Cli>\n        有肝肾功能减退者需调整剂量同时定期监测相关生化指标。\n      \u003C/li>\n      \u003Cli>\n        合并支持药物（如升白、补血、保肝药物）使用时，亦需明确剂量与间隔，配合主药疗程。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"custom-ovca-tip\">\n      \u003Cspan class=\"custom-tip-emoji\">🔄\u003C/span> 剂量调整严禁自行操作，需由专业医生根据监测结果评估后决定。\n    \u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"custom-ovca-section\" style=\"background: linear-gradient(90deg, #f9fbe7 70%, #fce4ec 100%);\">\n    \u003Ch2 class=\"custom-ovca-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04. 药物相互作用与合理联用 🔗\u003C/h2>\n    \u003Cp class=\"custom-ovca-p\">\n      复发性卵巢癌化疗药常需联用，一旦搭配不当，易造成药效降低、不良反应增加。\n    \u003C/p>\n    \u003Cul class=\"custom-ovca-ul\">\n      \u003Cli>\n        \u003Cb>铂类+紫杉烷类联用\u003C/b>时，顺序非常关键。建议先用紫杉烷类，后用铂类，有利于降低骨髓抑制等毒性（McGuire et al., 1996）。\n      \u003C/li>\n      \u003Cli>\n        PARP抑制剂与抗酸药同时使用，会影响吸收，应至少间隔2小时服用。\n      \u003C/li>\n      \u003Cli>\n        与华法林、培美曲塞等药联用时，要警惕出血、肝肾毒性等危险，必须向医生反馈当前所有药品与保健品使用清单。\n      \u003C/li>\n      \u003Cli>\n        避免与有显著抑制或诱导肝脏代谢酶（如CYP3A4）的药物同服，常见包括某些抗生素、抗真菌药等。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"custom-ovca-tip\">\n      \u003Cspan class=\"custom-tip-emoji\">👀\u003C/span> 联合用药前，务必先咨询专业人员。\n    \u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"custom-ovca-section\" style=\"background: linear-gradient(90deg, #e8f5e9 65%, #e3e0f7 100%);\">\n    \u003Ch2 class=\"custom-ovca-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05. 典型不良反应与应对措施 🩺\u003C/h2>\n    \u003Cp class=\"custom-ovca-p\">\n      不同化疗药不良反应各有特点。例如，卡铂对骨髓抑制影响大，紫杉烷类可出现脱发与过敏，PARP抑制剂常见恶心、疲劳等。支持药物则用于缓解这些副作用。\n    \u003C/p>\n    \u003Cul class=\"custom-ovca-ul\">\n      \u003Cli>\n        骨髓抑制：表现为白细胞、血小板下降，需定期血常规监测。如出现发热、出血点，及时就医。\n      \u003C/li>\n      \u003Cli>\n        恶心呕吐：服用止吐药、注意饮食清淡，如果症状明显则调整药物方案。\n      \u003C/li>\n      \u003Cli>\n        过敏反应：如注射期间出现皮疹、憋气，需立即报告医务人员，暂停输液，必要时使用抗过敏药。\n      \u003C/li>\n      \u003Cli>\n        乏力、脱发等：注意营养补充，护理头皮，保持作息规律。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"custom-ovca-tip\">\n      \u003Cspan class=\"custom-tip-emoji\">📈\u003C/span> 临床数据显示，及时监测和联合支持药物，有助于降低不良反应发生率（Tewari et al., 2019）。\n    \u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"custom-ovca-section\" style=\"background: linear-gradient(90deg, #f3e5f5 70%, #e0f7fa 100%);\">\n    \u003Ch2 class=\"custom-ovca-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06. 用药禁忌与特殊人群警示 🚫\u003C/h2>\n    \u003Cp class=\"custom-ovca-p\">\n      化疗药的使用存在严格禁忌。以下几类情况需特别注意：\n    \u003C/p>\n    \u003Cul class=\"custom-ovca-ul\">\n      \u003Cli>\n        对药物成分有明确过敏史者，严禁使用相关药物。\n      \u003C/li>\n      \u003Cli>\n        孕妇、哺乳期女性使用化疗药须充分权衡，绝大多数禁用。\n      \u003C/li>\n      \u003Cli>\n        有严重肝肾损伤者，部分药物需减量或停用。\n      \u003C/li>\n      \u003Cli>\n        与利福平、苯妥英等强酶诱导剂一起用药时易导致疗效下降，如无法避免，需密切动态监测。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"custom-ovca-tip\">\n      \u003Cspan class=\"custom-tip-emoji\">⚠️\u003C/span> 遭遇禁忌情况时，应立即告知医生并更换药物方案。\n    \u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"custom-ovca-section\" style=\"background: linear-gradient(90deg, #fff3e0 60%, #e3f2fd 100%);\">\n    \u003Ch2 class=\"custom-ovca-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07. 存储管理与药性保障 📦\u003C/h2>\n    \u003Cp class=\"custom-ovca-p\">\n      化疗药、辅助药大多需避光、密封、常温保存（15-30℃），部分生物制剂须置于2-8℃冷藏。开封后药物应标记日期，最长一般不超过1个月。如果药物出现变色、异味、片剂松散，需立即停用并妥善处理。\n    \u003C/p>\n    \u003Cp class=\"custom-ovca-p\">\n      过期药品不可任意丢弃，应按医疗废弃物要求处理或交由医疗机构回收，避免污染环境或他人误用。\n    \u003C/p>\n    \u003Cp class=\"custom-ovca-tip\">\n      \u003Cspan class=\"custom-tip-emoji\">🔒\u003C/span> 存放药品远离儿童及宠物，防止意外服药。\n    \u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"custom-ovca-section\" style=\"background: linear-gradient(90deg, #fce4ec 70%, #fffde7 100%);\">\n    \u003Ch2 class=\"custom-ovca-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08. 典型用药经验分享 🌱\u003C/h2>\n    \u003Cul class=\"custom-ovca-ul\">\n      \u003Cli>\n        一位72岁女性在使用PARP抑制剂联合卡铂期间，发现定期检测白细胞和肝功能，有效提前发现骨髓抑制，及时调整支持药物，顺利完成多个疗程。\n      \u003C/li>\n      \u003Cli>\n        临床中，老年患者采取分次给药+减少剂量策略后，不良反应发生率大大降低，并没有影响主要疗效。\n      \u003C/li>\n      \u003Cli>\n        实践表明，先用紫杉烷类再用铂类联合方案较倒序用药，副作用轻，依从性高（McGuire et al., 1996）。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\n  \u003Cdiv class=\"custom-ovca-section\" style=\"background: linear-gradient(90deg, #fff8e1 65%, #f3e5f5 100%);\">\n    \u003Ch2 class=\"custom-ovca-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09. 总结与提醒 🔍\u003C/h2>\n    \u003Cp class=\"custom-ovca-p\">\n      复发性卵巢癌的化疗药物种类多、细节多。正确的服用方法、密切监测不良反应、科学储存、避免与不宜同服药物联用，是安全用药的几大关键。遇到用药难题或突发情况时，请把药品名称、用量、具体服用情况如实告知医生。如果还有疑问，可随时咨询药师，做到明明白白用药、减少不必要的风险。\n    \u003C/p>\n    \u003Cp class=\"custom-ovca-highlighted\">\n      \u003Cspan class=\"custom-tip-emoji\">⭐\u003C/span> 最重要的两点：不自行调整剂量，遇到新情况/异常反应第一时间请专业人员评估！\n    \u003C/p>\n    \u003Cp class=\"custom-ovca-p custom-ovca-thankyou\">\n      关注这些核心用药细节，让疗效和安全同行，让治疗更放心。\n    \u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"custom-ovca-section custom-ovca-footer\" style=\"background: #e3f2fd;\">\n    \u003Ch3 class=\"custom-ovca-h3\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献\u003C/h3>\n    \u003Col class=\"custom-ovca-ref-list\">\n      \u003Cli>\n        Ledermann, J., Harter, P., Gourley, C., Friedlander, M., Vergote, I., Rustin, G., ... & Matulonis, U. (2012). Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer. \u003Ci>New England Journal of Medicine\u003C/i>, 366(15), 1382-1392.\n      \u003C/li>\n      \u003Cli>\n        McGuire, W. P., Hoskins, W. J., Brady, M. F., Kucera, P. R., Partridge, E. E., Look, K. Y., ... & Johnson, G. (1996). Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and IV ovarian cancer. \u003Ci>New England Journal of Medicine\u003C/i>, 334(1), 1-6.\n      \u003C/li>\n      \u003Cli>\n        Tewari, K. S., Monk, B. J., Vergote, I., Miller, D. S., Oaknin, A., Dutcus, C. E., ... & Lorusso, D. (2019). Survival with cediranib and olaparib in recurrent platinum-sensitive ovarian cancer. \u003Ci>New England Journal of Medicine\u003C/i>, 381(9), 811-821.\n      \u003C/li>\n    \u003C/ol>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.custom-ovca-container {\n  font-family: \"Hiragino Sans GB\", \"Microsoft YaHei\", Arial, Helvetica, sans-serif;\n  max-width: 820px;\n  margin: 30px auto 40px auto;\n  background: #fcfcfb;\n  border-radius: 16px;\n  box-shadow: 0 6px 24px 0 rgba(170,180,200,.12), 0 1.5px 6px 0 rgba(0,0,30,.04);\n  padding: 32px 28px;\n  color: #273148;\n}\n\n.custom-ovca-title {\n  font-size: 2.3rem;\n  font-weight: 700;\n  color: #222235;\n  margin-bottom: 32px;\n  text-align: left;\n  letter-spacing: 1.5px;\n}\n\n.custom-ovca-section {\n  margin-bottom: 34px;\n  border-radius: 12px;\n  padding: 24px 20px 20px 24px;\n  box-sizing: border-box;\n  border-left: 4px solid #6777b7;\n  transition: background 0.2s;\n  min-height: 82px;\n}\n\n.custom-ovca-section:last-child {\n  margin-bottom: 0;\n}\n\n.custom-ovca-h2 {\n  font-size: 1.48rem;\n  font-weight: 600;\n  color: #464e7c;\n  margin-bottom: 19px;\n  margin-top: 0;\n  position: relative;\n  z-index: 2;  \n}\n\n.custom-ovca-h3 {\n  font-size: 1.18rem;\n  font-weight: bold;\n  margin-bottom: 10px;\n  margin-top: 0;\n  color: #5b4a8e;\n  letter-spacing: .2px;\n}\n\n.custom-ovca-p {\n  font-size: 1.08rem;\n  line-height: 1.95;\n  color: #253057;\n  margin-bottom: 13px;\n  margin-top: 0;\n  text-align: left;\n}\n\n.custom-ovca-thankyou {\n  color: #7986cb;\n  font-size: 1.13rem;\n}\n\n.custom-ovca-tip {\n  margin: 12px 0 6px 0;\n  color: #176076;\n  font-size: 1.02rem;\n  line-height: 1.7;\n  background: rgba(222, 236, 248, 0.4);\n  border-left: 4px solid #7fb9c7;\n  padding: 9px 17px;\n  border-radius: 7px;\n  font-weight: 500;\n  display: flex;\n  align-items: center;\n}\n\n.custom-tip-emoji {\n  font-size: 1.45em;\n  margin-right: 7px;\n}\n\n.custom-ovca-ul {\n  padding-left: 1.5em;\n  margin-top: 0;\n  margin-bottom: 10px;\n}\n\n.custom-ovca-ul li {\n  line-height: 1.9;\n  font-size: 1.03rem;\n  margin-bottom: 7px;\n  color: #48536a;\n}\n\n.custom-ovca-highlighted {\n  background: linear-gradient(90deg,#f5f5f5 70%,#ede7f6 100%);\n  border-left: 4px solid #faa933;\n  font-size: 1.09rem;\n  color: #644311;\n  font-weight: 500;\n  padding: 10px 18px;\n  margin: 18px 0 12px 0;\n  border-radius: 6px;\n  display: flex;\n  align-items: center;\n}\n\n.custom-ovca-ref-list {\n  font-size: 0.97rem;\n  line-height: 1.85;\n  color: #5e5870;\n  padding-left: 16px;\n  margin-bottom: 0;\n}\n\n.custom-ovca-footer {\n  border: none;\n  margin-top: 45px;\n  font-size: 0.99rem;\n}\n\n@media (max-width: 560px) {\n  .custom-ovca-container {\n    padding: 12px 3vw;\n    max-width: 98vw;\n  }\n  .custom-ovca-section {\n    padding: 16px 7px 12px 9px;\n  }\n  .custom-ovca-title {\n    font-size: 1.25rem;\n    line-height: 1.3;\n    margin-bottom: 18px;\n  }\n  .custom-ovca-h2 {\n    font-size: 1.08rem;\n  }\n}\n\u003C/style>\n\n","\u003Cdiv class=\"custom-ovca-container\">\n  \u003Ch2 id=\"material_title\" class=\"custom-ovca-title\" style=\"color",535,"2025-09-19 10:34:47","复发性卵巢癌, 化疗药物, 安全用药, 药物相互作用, 不良反应","掌握复发性卵巢癌化疗药物的7个核心用药细节，确保安全有效的治疗。了解药物组成、用法及管理，提升治疗效果和信心。","2025-10-14 10:00:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]